Evidence map›Paper›PMID 37001052›Full record

ArticleThe British journal of radiology2023

Test-retest, inter- and intra-rater reproducibility of size measurements of focal bone marrow lesions in MRI in patients with multiple myeloma.

Markus Wennmann, Martin Grözinger, Vivienn Weru, Thomas Hielscher, Lukas Thomas Rotkopf, Fabian Bauer, Regula Gnirs, Tobias Nonnenmacher, Sandra Sauer, Hartmut Goldschmidt and 5 more

Abstract read
In one paragraph

Article in The British journal of radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Markus WennmannDivision of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0002-8092-8380
Martin GrözingerDivision of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Vivienn WeruDivision of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Thomas HielscherDivision of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Lukas Thomas RotkopfDivision of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Fabian BauerDivision of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Regula GnirsDivision of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Tobias NonnenmacherDiagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany.
Sandra SauerDepartment of Medicine V, Multiple Myeloma Section, University Hospital Heidelberg, Heidelberg, Germany.
Hartmut GoldschmidtDepartment of Medicine V, Multiple Myeloma Section, University Hospital Heidelberg, Heidelberg, Germany.
Niels WeinholdDepartment of Medicine V, Multiple Myeloma Section, University Hospital Heidelberg, Heidelberg, Germany.
David BonekampDivision of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Tim Frederik WeberDiagnostic and Interventional Radiology, University Hospital Heidelberg, Heidelberg, Germany.
Heinz-Peter SchlemmerDivision of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Stefan DelormeDivision of Radiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the reproducibility of size measurements of focal bone marrow lesions (FL) in MRI in patients with monoclonal plasma cell disorders under variation of patient positioning and observer.

methodsA data set from a prospective test-retest study was used, in which 37 patients with a total of 140 FL had undergone 2 MRI scans with identical parameters after patient repositioning. Two readers measured long and short axis diameter on the initial scan in

resultsIn the simple test-retest experiment with one identical reader, a deviation of ≥1 mm / ≥2 mm / ≥3 mm for the long axis diameter in

conclusionSmall deviations in FL size are common and probably due to variation in patient positioning or inter-rater variability alone, without any actual biological change of the FL. Knowledge of the uncertainty associated with size measurements of FLs is critical for radiologists and oncologists when interpreting changes in FL size in clinical practice and in clinical trials. ADVANCES IN KNOWLEDGE: According to the MY-RADs criteria, size measurements of focal lesions in MRI are now of relevance for response assessment in patients with monoclonal plasma cell disorders.Size changes of 1 or 2 mm are frequently observed due to uncertainty of the measurement only, while the actual focal lesion has not undergone any biological change.Size changes of at least 6 mm or more in

Indexed as

Bone DiseasesMultiple MyelomaBone MarrowHumansMagnetic Resonance ImagingProspective StudiesReproducibility of ResultsRetrospective Studies

Identifiers

PMID37001052
PMCPMC10161907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.